SPP100 in Biological Technology
Anavex appoints Dr. Dimitri Goundis to lead Clinical Development
...peedel AG. During his tenure, Dr. Goundis led the successful
development of spp100
from Phase I through Phase IIb clinical trials, at
which time Novartis exercised its license-back option. Today, spp100
sold in the United States under the trade name Tekturna and in Europe un...
SPP100 in other areas